Elderly-onset Crohn's disease remarkably responsive to ustekinumab: a case report.
Maho IwamotoKimitoshi KatoMitsuhiko MoriyamaPublished in: International journal of colorectal disease (2019)
Ustekinumab is an effective treatment option for elderly patients with intractable Crohn's disease when TNF-alpha inhibitors are ineffective.